Findings set stage for first clinical trial of stem cell-based therapeutic approach for AMD. Using a novel patient-specific stem cell-based therapy, researchers at the National Eye Institute (NEI) prevented blindness in animal models of geographic atrophy, the advanced “dry” form of age-related macular degeneration (AMD). The protocols established by the animal study* set the stage […]
Kodiak Sciences Inc. has announced promising results from their Phase 1 clinical trial of KSI-301, a novel anti-VEGF compound for the treatment of age-related macular degeneration, retinal vein occlusion, and diabetic macular edema. Currently approved anti-VEGF drugs require several monthly “loading dosages” at the beginning of the treatment regimen. Twelve weeks after a single dose […]
Neovascularization is the term applied to growth of errant blood vessels into the retina. This can occur whenever the retina is compromised by diseases such as age-related macular degeneration, myopic degeneration, or diabetic macular edema. Neovascularization is initially identified during dilated eye examinations, the scheduling of which depends upon the patient’s initiative in acquiring and […]
Prevent Blindness marks January’s National Glaucoma Awareness Month by Offering Information and Resources for Patients and Caregivers Today, nearly three million people ages 40 and older have glaucoma, according to the Prevent Blindness report, “Future of Vision: Forecasting the Prevalence and Costs of Vision Problems.” Those numbers are projected to increase steadily as more baby […]
A well-known standard for publishing for low vision readers has been incorporation of large print, clear fonts, and bold lettering. Now a small study has shown that bold lettering may not be as important as previously thought. A team of researchers reported in December 2018 to the newsfeed of Science Direct that increasing boldness of […]
Scientists are one step closer to developing an eye drop that could revolutionize treatment for wet age-related macular degeneration (wAMD). The condition is currently treated by injections of anti-VEGF drugs into the eye. Eye drops have been tested successfully in rats, but scientists have now investigated the effect of eye drops in the larger eyes […]
‘Twas the night before Christmas, when all through the house Not a creature was stirring, not even a mouse. My stocking was hung by the chimney with care, But I ripped it right down when I tripped on the chair. Then out on the lawn I heard such a clatter, I rose from the floor to […]
Diabetes can lead to complications resulting in partial or complete vision loss. The Vision Bill of Rights is a global initiative raising awareness about protecting the vision of the 425 million people worldwide who are living with diabetes. Created by 18 diabetes and low vision advocacy groups around the world, the Vision Bill of Rights […]
A report published in Review of Optometry on November 5, 2018 announced research* showing that non-anemic patients with wet age-related macular degeneration (wAMD) who take oral iron supplements may be at risk of retinal/subretinal hemorrhage. Researchers have found that use of oral iron supplements was significantly associated with retinal/subretinal hemorrhage at baseline in patients with […]
Genentech has announced positive results from the Phase II STAIRWAY study which explored the extended durability of faricimab (RG7716) in the treatment of wet age-related macular degeneration (AMD). At 52 weeks, faricimab patients dosed either every 16 weeks or every 12 weeks demonstrated sustained vision outcomes comparable to Lucentis (ranibizumab) dosed every four weeks. “Because […]